BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Nextbiomedical Secures FDA IDE Approval for U.S. Clinical Trial of Nexsphere-F™ in Knee Osteoarthritis

NEXTBIOMEDICAL CO., LTD, a KOSDAQ-listed innovative medical device company in South Korea, proudly announced that it has received Investigational Devi...

January 16, 2025 | News

CMU Hosts International Forum Showcasing Taiwan’s Leadership in Extracellular Vesicle Technology

China Medical University (CMU) and Healthcare System hosted the International Forum of Extracellular Vesicles Technology and Novel Therapeutics to highligh...

January 16, 2025 | News

R-Bridge Healthcare Fund Provides $40M Financing to Mirxes to Accelerate Global Expansion of Cancer Early Detection Solutions

R-Bridge will provide bespoke financing of US$40 million with a synthetic royalty structure and f...

January 14, 2025 | News

Regor’s Oral GLP-1RA RGT-075 Shows 5% Placebo-Adjusted Weight Loss in Phase 2a Trial with Strong Safety Profile

Regor announced its 12-week single-dose Phase 2a trial results for RGT-075, a once-daily oral GLP-1RA, reporting 5% placebo-adjusted weight-loss with no ...

January 13, 2025 | News

MSD’s GARDASIL® Becomes First HPV Vaccine Approved for Males in China

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the National Medical Products Administration (NMPA) of China ...

January 10, 2025 | News

DIOSynVax Introduces New Influenza Vaccine Portfolio and Advisory Board to Tackle Global Pandemic Threats

DIOSynVax, a clinical-stage biotechnology company at the forefront of developing innovative, broadly protective vaccines, built on the safety demonstrated ...

January 09, 2025 | News

Zuellig Pharma Acquires Propan to Strengthen Consumer Health Portfolio in the Philippines

Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that it has completed the acquisition of Propan, a market leading brand in th...

January 07, 2025 | News

Technoderma Medicines Announces Positive Phase 2a Results for TDM-180935 in Atopic Dermatitis

Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased to report the Company has completed its Phase 2a clinic...

January 07, 2025 | News

Docquity and HCDC Join Forces to Advance Preventive Medicine Education for Over 3,000 Vietnamese HCPs

Through this multi-year initiative, HCDC will tap on Docquity’s digital capabilities and reach to arm over 3,000 HCPs across diverse fields with brea...

January 06, 2025 | News

Human Metapneumovirus Sparks Concern Across Asia: India Joins Global Vigilance

The detection of Human Metapneumovirus (HMPV) in Karnataka, India, and a rising number of cases across Asia have prompted heightened vigilance among health...

January 06, 2025 | Analysis

Inogen Secures FDA Clearance for SIMEOX 200 Airway Clearance Device

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced tha...

January 02, 2025 | News

AHF Urges ASEAN to Lead Regional Efforts to End AIDS as a Public Health Threat

AIDS Healthcare Foundation (AHF), the world’s largest nonprofit provider of HIV/AIDS medical care, has called on the Association of Southeast Asian N...

January 01, 2025 | News

Huadong Medicine and SynerK PharmaTech Forge Strategic Alliance to Develop siRNA Drug for Hypertension

Hangzhou Sino-US Huadong Medicine Co., Ltd. (hereinafter referred to as "Huadong Medicine"), a wholly-owned subsidiary of Huadong Medicine Co., Ltd. (SZ.00...

December 30, 2024 | News

BGM Group Enters AI-Driven Healthcare and Insurance Sector with Strategic Acquisition of AIX Inc.

BGM Group Ltd. (Nasdaq: BGM) (the "Company" or "BGM"), a leading global pharmaceutical enterprise, announced completion of the acquisition of the int...

December 30, 2024 | News

Stay Connected